Skip to main content
. 2020 Mar 18;183(6):1073–1082. doi: 10.1111/bjd.18959

Table 1.

Participant characteristics (including professional characteristics) (n = 229)

Characteristic n (%)
Age (years)
20–30 16 (7·0)
31–40 54 (23·6)
41–50 66 (28·8)
51–60 67 (29·3)
> 60 26 (11·4)
Sex
Female 135 (59·0)
Male 94 (41·0)
Type of workplace
Community 1 (0·4)
General hospital 38 (16·6)
Private practice 42 (18·3)
University teaching hospital 148 (64·6)
Years of experience
0–4 14 (6·1)
5–10 45 (19·7)
11–20 70 (30·6)
> 20 100 (43·7)
Number of treated patients per 3 months
< 10 30 (13·1)
10–50 116 (50·7)
51–100 58 (25·3)
101–200 17 (7·4)
> 200 8 (3·5)
Patients with moderate‐to‐severe AE in the population
< 5% 34 (14·8)
5–10% 59 (25·8)
11–25% 55 (24·0)
26–40% 31 (13·5)
41–60% 24 (10·5)
> 60% 26 (11·4)
Number of initiated patients on photo‐ or systemic therapy per 3 months
0 1 (0·4)
1–5 109 (47·6)
6–10 62 (27·1)
11–20 35 (15·3)
> 20 22 (9·6)
Ethnicity of the majority of patientsa
White 225 (98·3)
Ethnicities of patients seen occasionallya
Asian Chinese 174 (76·0)
Black African/Afro‐Caribbean 161 (70·3)
South Asian 158 (69·0)
Asian – other 142 (62·0)
Hispanic/Latino 139 (60·7)
Five most frequently used measurement instrumentsa
SCORing Atopic Dermatitis 155 (67·7)
Dermatology Life Quality Index 129 (56·3)
Eczema Area and Severity Index 125 (54·6)
Investigator's Global Assessment 77 (33·6)
Visual analogue scale for itch 53 (23·1)

AE, atopic eczema. aParticipants were able to select multiple options.